Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSD | P07339 | 1/20 | 0.49 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | CA7 | P43166 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.44 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.44 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.44 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.44 |
| ▸ | TLR2 | O60603 | 1/20 | 0.43 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.43 |
| ▸ | TLR6 | Q9Y2C9 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Toluene SCHEMBL28590386 | 0.92 | RAB9A (0.48) | CTSDCA12CA1CA2CA7 | |
| SCHEMBL7496866 | 0.82 | MAPT (0.46) | CTSDCA12CA1CA2CA7 | |
| SCHEMBL698393 | 0.82 | LMNA (0.53) | CTSDCA12CA1CA2CA7 | |
| SCHEMBL311839 | 0.82 | HTT (0.59) | CA12CA1CA2CA7CA9 | |
| SCHEMBL29959614 | 0.82 | HTT (0.59) | CA12CA1CA2CA7CA9 | |
| SCHEMBL431 | 0.82 | CTSD (0.63) | CTSDHTTKCNK3KCNK9 | |
| SCHEMBL29392137 | 0.82 | CTSD (0.63) | CTSDHTTKCNK3KCNK9 | |
| SCHEMBL414201 | 0.81 | ACHE (0.56) | HTT | |
| SCHEMBL2300929 | 0.81 | ALDH1A1 (0.50) | — | |
| SCHEMBL9357148 | 0.81 | JAK2 (0.56) | CTSDCA12CA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 153 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113248351-B | Preparation method of 6-chloro-2-methoxytoluene and synthetic process of methoxyfenozide | 绍兴上虞新银邦生化有限公司 | 2022-10-11 | — | — | CN | claimed |
| CN-113105323-B | Green preparation process of 2-methyl-3-methoxybenzoyl chloride | 江苏永安化工有限公司 | 2022-07-19 | — | — | CN | claimed |
| CN-113248351-A | Preparation method of 6-chloro-2-methoxytoluene and synthetic process of methoxyfenozide | 绍兴上虞新银邦生化有限公司 | 2021-08-13 | — | — | CN | claimed |
| CN-113105323-A | Green preparation process of 2-methyl-3-methoxybenzoyl chloride | 江苏永安化工有限公司 | 2021-07-13 | — | — | CN | claimed |
| CN-110627678-A | Synthesis process of methoxyfenozide | 李德平 | 2019-12-31 | — | — | CN | claimed |
| CN-109384667-A | A kind of synthesis technology of 2- methyl -3- methoxy benzoyl chloride | 江苏永安化工有限公司 | 2019-02-26 | — | — | CN | claimed |
| CN-108828121-A | A kind of white detection method of content for setting the high nojirimycin of α-in medicinal material | 华润三九医药股份有限公司 | 2018-11-16 | — | — | CN | claimed |
| CN-107176908-A | A kind of synthetic method of the methoxy benzoyl chloride of 2 methyl 3 | 江苏科菲特生化技术股份有限公司 | 2017-09-19 | — | — | CN | claimed |
| EP-0639559-B1 | Preparation of 1,2-diacyl-2-(t-alkyl)hydrazines | ROHM & HAAS (US) | 1997-10-15 | — | — | EP | claimed |
| EP-0639559-A1 | Preparation of 1,2-diacyl-2-(t-alkyl)hydrazines | ROHM AND HAAS COMPANY (US) | 1995-02-22 | — | — | EP | claimed |
| US-12441708-B2 | Cereblon ligands and bifunctional compounds comprising the same | ARVINAS OPERATIONS, INC. (US) | 2025-10-14 | — | — | US | disclosed |
| US-20250313547-A1 | CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME | ARVINAS OPERATIONS INC (US) | 2025-10-09 | — | — | US | disclosed |
| CN-113896712-B | Diamide compound containing cyclic amino acid | 华东理工大学 | 2024-04-09 | — | — | CN | disclosed |
| CN-110612294-B | Human cerebulin ligands and bifunctional compounds comprising same | 阿尔维纳斯运营股份有限公司 | 2024-01-16 | — | — | CN | disclosed |
| US-20230183209-A1 | CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME | ARVINAS OPERATIONS, INC. (US) | 2023-06-15 | — | — | US | disclosed |
| US-5344958-A | From 3-methoxy-2-(substituted)benzoic acid or ester | ROHM AND HAAS COMPANY (US) | 1994-09-06 | — | — | US | disclosed |
| EP-0602794-A2 | Insecticidal N'-substituted-N, N'-diacylhydrazines | ROHM AND HAAS COMPANY (US) | 1994-06-22 | — | — | EP | disclosed |
| WO-1993014086-A1 | SUBSTITUTED 1-ISOQUINOLONE DERIVATIVES AS ANGIOTENSIN II ANTAGONISTS | SYNTEX (U.S.A.) INC. (US) | 1993-07-22 | — | — | WO | disclosed |
| CN-1057452-A | Dibenzoyl alkyl-alkyl cyanides | ROHM & HAAS (US) | 1992-01-01 | — | — | CN | disclosed |
| EP-0461809-A1 | Dibenzoylalkylcyanohydrazines | ROHM AND HAAS COMPANY (US) | 1991-12-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230183209-A1 | CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME | CRBN, CBL, MDM2 | CTSD 1381/4885CA12 2628/4885CA1 982/4885 |
| US-20250313547-A1 | CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME | CRBN, CBL, MDM2 | CTSD 1381/4885CA12 2628/4885CA1 982/4885 |
| US-12441708-B2 | Cereblon ligands and bifunctional compounds comprising the same | CRBN, CBL, MDM2 | CTSD 1381/4885CA12 2628/4885CA1 982/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.